Exane Derivatives Qiagen N.V. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Qiagen N.V. stock. As of the latest transaction made, Exane Derivatives holds 16,639 shares of QGEN stock, worth $719,470. This represents 0.5% of its overall portfolio holdings.
Number of Shares
16,639
Previous 14,886
11.78%
Holding current value
$719,470
Previous $729,000
7.68%
% of portfolio
0.5%
Previous 0.23%
Shares
10 transactions
Others Institutions Holding QGEN
# of Institutions
22Shares Held
6.37MCall Options Held
0Put Options Held
0-
Pendal Group LTD4.3MShares$186 Million1.76% of portfolio
-
Abeille Asset Management Sa931KShares$40.3 Million1.68% of portfolio
-
Grandeur Peak Global Advisors, LLC Salt Lake City, UT796KShares$34.4 Million3.21% of portfolio
-
Pictet Asset Management Sa Geneva 73, V8153KShares$6.64 Million0.01% of portfolio
-
Bdl Capital Management Paris, I088.8KShares$3.84 Million3.33% of portfolio
About QIAGEN N.V.
- Ticker QGEN
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 227,694,000
- Market Cap $9.85B
- Description
- QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...